Scroll Back to Top

Phase I Units 

The facilities you need to make rapid “go/no-go” decisions.

Connect with us

Gain the critical data needed to make earlier, more confident decisions. Leave it to us to manage the complexity of Phase I trials in healthy volunteers, patients and special populations with our global network of clinical research units (CRUs).

A network of support

Drive your clinical research with our state-of-the-art CRUs backed up by a network of specialist site partners.

Get essential expertise 

Leverage our in-house know-how as we manage the complexity of studies, react quickly to incoming data and speed toward an informed go/no-go decision.

On-site cGMP

Our on-site cGMP pharmacies simplify drug formulation and delivery.

CRU LocationMadison, WIDaytona Beach, FLDallas, TXLeeds, UK
Number of beds88 beds88 beds100100 beds
Size42,000 ft2
(3,900m2)
40,000 ft2
(3,700m2)
55,000 ft2
(5,100m2)
6,000m2 
(65,000 ft2)
cGMP Pharmacy
Radiolabeled hAME studies

  
ClinSpark BDC
Asian ethno-bridging studies  
High visibility beds for monitoring1    
ECG and telemetry holter monitoring
Fibroscan
Ophthalmology suite
 
  
Dedicated screening area
 
  
Specialized procedures
 
Bile collectionCSF Collection, PBMCs, Bioimpedance Analysis, Local imaging (DEXA, MRI, Ultrasound)
 
 Human appetite lab, CSF collection2, skin & muscle biopsies, PBMC collection and preparation
 

1. High visibility beds are included in the total bed number count
2. Leeds, UK CSF collection (indwelling cannula or individual samples)


Managing complexity is our specialty

Advance your Phase I trial at one of our four CRUs strategically based in the U.S. and the U.K. These state-of-the-art facilities provide everything you need to advance complex research while promoting participant well-being.


Leeds Drapers Yard, U.K.

Our sustainably designed CRU in Leeds Drapers Yard combines our two former locations with 100 beds, a cGMP pharmacy, including two sterile and two nonsterile rooms, and increased capacity for ECG and telemetry Holter monitoring.

Daytona Beach, Florida

Encompassing an estimated population of more than 21 million people, our Daytona Beach CRU boasts a track record of delivering on a range of trials spanning FIH bioequivalence, bioavailability, definitive QTc, drug-drug interaction, proof-of-concept, rising dose and Phase IIa patient studies.

Madison, Wisconsin

Our Madison CRU is regarded as the global leader in the conduct of radiolabeled clinical studies. The site also includes a cGMP pharmacy, including two sterile and three nonsterile manufacturing suites.

Dallas, Texas

With a dedicated ophthalmology suite and a cGMP pharmacy, including two sterile and three nonsterile manufacturing suites that can manage and handle high-potency and hazardous drugs, our Dallas CRU supports inpatient and outpatient Phase I-IV clinical trials of investigational medications.

Testimonial

The team had excellent communication and knowledge about what was always needed during the course of the study, and they were able to adapt to timelines as changes occurred.

Early Clinical Scientist Large Pharma

They were able to adapt to timelines.